Step by Stepa HemeOncBuddy patient portal

7+3

Illustration: 7+3

Say it: SEV-en plus THREE

Cytarabine and daunorubicin, sometimes with midostaurin

7+3 is a strong first treatment for acute myeloid leukemia (AML), given during a hospital stay to clear leukemia cells from the blood and bone marrow.

Also called: 7 plus 3, 7 and 3, seven plus three, cytarabine and daunorubicin, 7+3 with midostaurin, 7+3 with gemtuzumab, induction chemo for AML

What it is

The name comes from the schedule: 7 days of cytarabine and 3 days of daunorubicin. The two medicines kill leukemia cells in different ways, so together they work better. This first phase is called induction, and the goal is remission (no leukemia seen in the bone marrow). After remission, more treatment is needed to keep the leukemia away, such as more chemotherapy or a stem cell transplant.

77 days of cytarabine
33 days of daunorubicin

Often used for

7+3 with midostaurin
Used when the leukemia has a FLT3 gene change. Midostaurin pills are added after the chemotherapy days and help people live longer.
7+3 with quizartinib
Another option for leukemia with a FLT3 gene change called FLT3 ITD. It is a daily pill added after the chemotherapy days.
7+3 with gemtuzumab ozogamicin
Used for some types of AML whose cells carry a marker called CD33, often lower risk types. It is an antibody linked to chemotherapy, given through a vein on a few days.
7+3 with idarubicin
Some centers use idarubicin in place of daunorubicin. It works in a similar way.

The medicines in this plan

Cytarabine
Chemotherapy that stops leukemia cells from copying their DNA. Given through a vein nonstop, all day and night, for 7 days.
Daunorubicin
An anthracycline chemotherapy (a red medicine). Given through a vein on days 1, 2 and 3.
Midostaurin
A targeted pill for leukemia with a FLT3 gene change. Taken twice a day with food, usually on days 8 to 21.

How you get it

7+3 is given in the hospital. You will usually stay about 3 to 5 weeks, until your blood counts recover enough to go home safely. A central line (a long tube placed in a large vein) is usually put in so medicines and blood can be given easily. A bone marrow test is often done around day 14 and again when counts recover. Your schedule may be different.

A typical cycle

Days 1 to 3
Cytarabine runs nonstop through your line. Daunorubicin is given through the line once each day.
Days 4 to 7
Cytarabine keeps running nonstop. Nausea medicines are given each day.
Days 8 to 21
Chemotherapy is done. If you have a FLT3 change, you take midostaurin pills twice a day. Blood counts drop very low, and you will likely need blood and platelet transfusions.
Around day 14
A bone marrow test may be done to see if leukemia cells are gone.
Days 21 to 35
Blood counts slowly recover. A bone marrow test checks for remission. You go home when it is safe.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Leukemia

Sources

Quick answers

What is 7+3?
7+3 is a strong first treatment for acute myeloid leukemia (AML), given during a hospital stay to clear leukemia cells from the blood and bone marrow. Cytarabine and daunorubicin, sometimes with midostaurin.
What does 7+3 stand for?
7 = 7 days of cytarabine; 3 = 3 days of daunorubicin.
How is 7+3 given?
7+3 is given in the hospital. You will usually stay about 3 to 5 weeks, until your blood counts recover enough to go home safely. A central line (a long tube placed in a large vein) is usually put in so medicines and blood can be given easily. A bone marrow test is often done around day 14 and again when counts recover. Your schedule may be different.
What are the common side effects of 7+3?
Very low blood counts. Fever while your white blood cells are low. Nausea and vomiting. Mouth sores. Hair loss, usually starting 2 to 3 weeks after treatment begins. Diarrhea. Red or pink urine for a day or two after daunorubicin. Rash or red, itchy eyes from cytarabine. Feeling very tired and weak.
When should I call my care team during 7+3?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Bleeding that will not stop, nosebleeds, blood in urine or stool, or many new bruises; Trouble breathing, chest pain, or a racing heartbeat; New confusion, a very bad headache, or trouble with balance or speech; Shaking chills or feeling faint when the IV line is flushed; Redness, pain, swelling or pus around your central line; After going home: any of the above, or you cannot eat or drink.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.